2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry

[1]  E. Nagel,et al.  European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries , 2013, Journal of Cardiovascular Magnetic Resonance.

[2]  M. Han,et al.  Immediate hypersensitivity reaction to gadolinium-based MR contrast media. , 2012, Radiology.

[3]  E. Nagel,et al.  Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. , 2011, JACC. Cardiovascular imaging.

[4]  M. Prince,et al.  Incidence of immediate gadolinium contrast media reactions. , 2011, AJR. American journal of roentgenology.

[5]  Lluís Armadans,et al.  Hospital de la Santa Creu i Sant Pau , 2011 .

[6]  Vijaya Kosaraju,et al.  Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections. , 2010, AJR. American journal of roentgenology.

[7]  A. Elster.  Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses , 2010 .

[8]  E. Nagel,et al.  Current variables, definitions and endpoints of the European Cardiovascular Magnetic Resonance Registry , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[9]  E. Nagel,et al.  EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. , 2009, Journal of the American College of Cardiology.

[10]  E. Nagel,et al.  European cardiovascular magnetic resonance (EUROCMR) registry – preliminary results of the German pilot phase , 2009, Journal of Cardiovascular Magnetic Resonance.

[11]  E. Kanal,et al.  Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. , 2008, AJR. American journal of roentgenology.

[12]  Richard H. Cohan,et al.  Frequency and Severity of Acute Allergic-Like Reactions to Gadolinium-Containing IV Contrast Media in Children and Adults , 2007 .

[13]  Manesh R. Patel,et al.  ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group. , 2006, Journal of the American College of Radiology : JACR.

[14]  C. Wong,et al.  Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates. , 2006, The British journal of radiology.

[15]  James C Carr,et al.  ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Ra , 2006, Journal of the American College of Cardiology.

[16]  J. Brunberg,et al.  Adverse reactions to gadolinium contrast media: a review of 36 cases. , 1996, AJR. American journal of roentgenology.

[17]  K. L. Nelson,et al.  Clinical safety of gadopentetate dimeglumine. , 1995, Radiology.

[18]  Albert Soiland,et al.  The American College of Radiology , 1924 .